Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.98 HKD | -1.19% | -5.16% | -25.30% |
May. 02 | Alphamab Oncology's 2023 Loss Narrows as Revenue Rises | MT |
Apr. 10 | Alphamab Oncology Presents Phase-I Clinical Trial Results at 2024 AACR Annual Meeting | MT |
Sales 2023 | 219M 30.28M 237M | Sales 2024 * | 246M 34.09M 266M | Capitalization | 4.49B 621M 4.85B |
---|---|---|---|---|---|
Net income 2023 | -211M -29.21M -228M | Net income 2024 * | -299M -41.39M -324M | EV / Sales 2023 | 22.8 x |
Net cash position 2023 | 829M 115M 897M | Net cash position 2024 * | 549M 75.98M 594M | EV / Sales 2024 * | 16 x |
P/E ratio 2023 |
-27.4
x | P/E ratio 2024 * |
-15
x | Employees | 435 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 49.21% |
1 day | -1.59% | ||
1 week | -5.16% | ||
Current month | +4.42% | ||
1 month | +6.90% | ||
3 months | +12.47% | ||
6 months | -60.94% | ||
Current year | -25.30% |
Managers | Title | Age | Since |
---|---|---|---|
Ting Xu
CEO | Chief Executive Officer | 51 | 08-10-31 |
Jing Han
CMP | Compliance Officer | 51 | 21-11-01 |
Jinbo Wang
CTO | Chief Tech/Sci/R&D Officer | 50 | 18-03-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cheng Wei
BRD | Director/Board Member | 56 | 19-11-23 |
Ting Xu
CEO | Chief Executive Officer | 51 | 08-10-31 |
Yang Liu
COO | Chief Operating Officer | 52 | 18-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.21% | 4 M€ | -27.92% | ||
0.06% | 2 M€ | -14.14% | ||
0.01% | 4 M€ | -4.41% | - | |
0.00% | 0 M€ | +3.30% | - | |
0.00% | 0 M€ | +3.53% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 4.98 | -1.19% | 1 042 000 |
24-05-07 | 5.04 | -2.51% | 3,128,700 |
24-05-06 | 5.17 | -0.39% | 2,749,300 |
24-05-03 | 5.19 | -0.76% | 409,700 |
24-05-02 | 5.23 | +10.11% | 1,050,800 |
Delayed Quote Hong Kong S.E., May 08, 2024 at 01:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.30% | 622M | |
+21.74% | 46.4B | |
-0.97% | 41.75B | |
+47.07% | 41.37B | |
-3.52% | 29.71B | |
+11.12% | 26.01B | |
-19.37% | 19.52B | |
+31.18% | 12.43B | |
-0.04% | 12.13B | |
+0.39% | 12.18B |
- Stock Market
- Equities
- 9966 Stock